Teleflex Incorporated (TFX) Shares Sold by Guyasuta Investment Advisors Inc.
Guyasuta Investment Advisors Inc. lessened its holdings in shares of Teleflex Incorporated (NYSE:TFX) by 16.1% in the 2nd quarter, according to its most recent filing with the SEC. The fund owned 5,195 shares of the medical technology company’s stock after selling 1,000 shares during the period. Guyasuta Investment Advisors Inc.’s holdings in Teleflex were worth $1,079,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also bought and sold shares of TFX. Marshall Wace North America L.P. lifted its position in shares of Teleflex by 137.4% during the 2nd quarter. Marshall Wace North America L.P. now owns 518,462 shares of the medical technology company’s stock worth $107,840,000 after purchasing an additional 300,069 shares during the last quarter. Principal Financial Group Inc. lifted its position in shares of Teleflex by 93.5% during the 2nd quarter. Principal Financial Group Inc. now owns 610,398 shares of the medical technology company’s stock worth $126,816,000 after purchasing an additional 294,935 shares during the last quarter. FMR LLC lifted its position in shares of Teleflex by 46.5% during the 1st quarter. FMR LLC now owns 811,764 shares of the medical technology company’s stock worth $157,263,000 after purchasing an additional 257,649 shares during the last quarter. MARSHALL WACE ASIA Ltd acquired a new position in shares of Teleflex during the 1st quarter worth about $42,368,000. Finally, Vanguard Group Inc. lifted its position in shares of Teleflex by 5.2% during the 1st quarter. Vanguard Group Inc. now owns 3,781,475 shares of the medical technology company’s stock worth $732,584,000 after purchasing an additional 186,845 shares during the last quarter. 90.50% of the stock is owned by institutional investors and hedge funds.
TFX has been the subject of several research analyst reports. Zacks Investment Research raised Teleflex from a “hold” rating to a “buy” rating and set a $228.00 price objective for the company in a research report on Friday, June 23rd. Barclays PLC reissued a “buy” rating on shares of Teleflex in a research report on Monday, June 26th. Deutsche Bank AG boosted their price target on Teleflex from $213.00 to $220.00 and gave the company a “buy” rating in a research note on Monday, May 8th. Leerink Swann boosted their price target on Teleflex from $215.00 to $220.00 and gave the company a “market perform” rating in a research note on Friday, June 9th. Finally, BidaskClub lowered Teleflex from a “buy” rating to a “hold” rating in a research note on Monday, July 31st. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and six have assigned a buy rating to the stock. The company has a consensus rating of “Buy” and an average price target of $228.67.
Teleflex Incorporated (TFX) traded down 0.59% during midday trading on Monday, hitting $210.51. The stock had a trading volume of 149,928 shares. Teleflex Incorporated has a 1-year low of $136.53 and a 1-year high of $217.97. The company has a market cap of $9.48 billion, a price-to-earnings ratio of 40.26 and a beta of 1.05. The company’s 50 day moving average is $210.26 and its 200 day moving average is $201.24.
Teleflex (NYSE:TFX) last issued its quarterly earnings data on Thursday, August 3rd. The medical technology company reported $2.04 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.91 by $0.13. The firm had revenue of $528.60 million during the quarter, compared to the consensus estimate of $518.98 million. Teleflex had a net margin of 12.36% and a return on equity of 16.12%. The business’s revenue for the quarter was up 11.6% compared to the same quarter last year. During the same period last year, the business posted $1.89 earnings per share. On average, equities analysts anticipate that Teleflex Incorporated will post $8.28 earnings per share for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, September 15th. Stockholders of record on Tuesday, August 15th will be issued a dividend of $0.34 per share. The ex-dividend date of this dividend is Friday, August 11th. This represents a $1.36 annualized dividend and a dividend yield of 0.65%. Teleflex’s dividend payout ratio is presently 26.00%.
TRADEMARK VIOLATION NOTICE: “Teleflex Incorporated (TFX) Shares Sold by Guyasuta Investment Advisors Inc.” was originally reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this article on another site, it was illegally copied and republished in violation of US and international copyright and trademark law. The correct version of this article can be viewed at https://www.thecerbatgem.com/2017/09/04/teleflex-incorporated-tfx-shares-sold-by-guyasuta-investment-advisors-inc.html.
In other news, Director Stuart A. Randle sold 2,500 shares of the firm’s stock in a transaction that occurred on Wednesday, June 7th. The shares were sold at an average price of $205.67, for a total transaction of $514,175.00. Following the transaction, the director now directly owns 7,532 shares of the company’s stock, valued at $1,549,106.44. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Gretchen R. Haggerty bought 1,000 shares of the stock in a transaction dated Wednesday, June 21st. The shares were acquired at an average cost of $203.82 per share, for a total transaction of $203,820.00. Following the completion of the acquisition, the director now directly owns 1,760 shares of the company’s stock, valued at approximately $358,723.20. The disclosure for this purchase can be found here. Insiders have sold 2,900 shares of company stock worth $597,477 over the last ninety days. Insiders own 2.39% of the company’s stock.
Teleflex Company Profile
Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through six segments: Vascular North America; Anesthesia North America; Surgical North America; Europe, the Middle East and Africa (EMEA); Asia, and Original Equipment Manufacturer (OEM).
Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFX).
Receive News & Stock Ratings for Teleflex Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex Incorporated and related stocks with our FREE daily email newsletter.